2010
DOI: 10.1136/jnnp.2009.197467
|View full text |Cite
|
Sign up to set email alerts
|

Predicting intracranial lesions by antiplatelet agents in subjects with mild head injury

Abstract: SUMMARYBackground: The effect of pre-injury antiplatelet treatment in the risk of intracranial lesions in

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
18
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 39 publications
(18 citation statements)
references
References 31 publications
(24 reference statements)
0
18
0
Order By: Relevance
“…11 These data were only partially confirmed because, in our study, the use of antiplatelet agents clearly interacted with age in the multivariate analysis.…”
Section: Discussionmentioning
confidence: 63%
“…11 These data were only partially confirmed because, in our study, the use of antiplatelet agents clearly interacted with age in the multivariate analysis.…”
Section: Discussionmentioning
confidence: 63%
“…Nonetheless, the mortality rate of subjects receiving aspirin was also reported to be higher than normal [33]. In cases observed in EDs, pre-injury antiplatelet therapy was recently shown to increase significantly the risk of intracranial lesions in subjects after mild head injury [34], whereas in a prospective study of mild and moderate head injury in subjects more than 60 years old, low-dose aspirin prophylaxis had no effect on the frequency or types of intracerebral or meningeal hemorrhage [35]. The initial size of the contusion and the presence of SDH were selected as predictors of radiological progression, and the initial GCS and younger age as predictors of good disposition at discharge [34], but much more evidence is required before a firm conclusion can be drawn.…”
Section: Discussionmentioning
confidence: 99%
“…The journal strives to identify key new developments and potential future discoveries in the constantly changing world of neuroscience. Traversing the realm of clinical neuroscience, we hope to uncover the citation classics of the future,8–17 while at the same time, catering to a more general audience with teaching and wider instruction in mind 18 19. Despite the challenges of an ever-changing medical publishing landscape, with the need to adapt and remain fresh (including the launch of our new cover image with this issue), we look forward to sharing the trail blazers with you over the coming year.…”
Section: Medical Publishing Metrics and Financial Yieldsmentioning
confidence: 99%